These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 7123121

  • 1. Interrelation at plasmatic level between antiepileptic drugs and lipids. Its implications in the efficiency of treatment in epilepsy. III. Changes induced by phenobarbital or/and diphenylhydantoin in serum lipids, lipoproteins and cortisol.
    Rogozea R, Florea-Ciocoiu V, Bălăiţă C, Luca N.
    Neurol Psychiatr (Bucur); 1982; 20(2):89-100. PubMed ID: 7123121
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Side effects of antiepileptic drugs].
    Rościszewska D.
    Neurol Neurochir Pol; 1984; 18(6):575-81. PubMed ID: 6399348
    [No Abstract] [Full Text] [Related]

  • 5. Serum level of phenobarbital or/and diphenylhydantoin in epileptics with some preexisting serum lipid alterations. Correlations with the treatment efficiency in epilepsy.
    Rogozea R, Florea-Ciocoiu V, Balaita C, Luca N.
    Acta Neurol Belg; 1981; 81(1):24-32. PubMed ID: 7223355
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Multivariate statistical methods in toxicology: application to the analysis of outpatient clinical data for diphenylhydantoin and phenobarbital in the treatment of epilepsy.
    Schaeffer DJ, Janardan KG, Somani SM, Easton D, Sherman D.
    Toxicol Appl Pharmacol; 1980 Apr; 53(2):354-64. PubMed ID: 7394776
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Hemostasis in epileptic patients treated with anticonvulsant drugs].
    de Pasquet EG, Ghiggino CW, Toledo S, Tenzer SM.
    Acta Neurol Latinoam; 1973 Apr; 19(1-4):67-77. PubMed ID: 4808368
    [No Abstract] [Full Text] [Related]

  • 14. Treatment of grand mal epilepsy: phenobarbital versus diphenylhydantoin sodium.
    Livingston S.
    Clin Pediatr (Phila); 1968 Aug; 7(8):444-5. PubMed ID: 4970064
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Letter: Teratogenic hazards in antiepileptic therapy].
    Loiseau P, Henry TP.
    Nouv Presse Med; 1974 Jan 12; 3(2):92. PubMed ID: 4815439
    [No Abstract] [Full Text] [Related]

  • 17. [Studies on the serum levels of the antiepileptic drugs-with particular reference to diphenylhydantoin, phenobarbital and carbamazepine-(author's transl)].
    Kurata K.
    Seishin Shinkeigaku Zasshi; 1979 Jan 12; 81(8):509-22. PubMed ID: 531122
    [No Abstract] [Full Text] [Related]

  • 18. Serum lipid changes during anticonvulsive treatment serum lipids in epileptic children.
    Yilmaz E, Doşan Y, Gürgöze MK, Güngör S.
    Acta Neurol Belg; 2001 Dec 12; 101(4):217-20. PubMed ID: 11851028
    [Abstract] [Full Text] [Related]

  • 19. Plasma hydroxyproline in epilepsy.
    Langgård H.
    Acta Neurol Scand; 1968 Dec 12; 44(3):387-90. PubMed ID: 5698415
    [No Abstract] [Full Text] [Related]

  • 20. Presenile cataracts in phenytoin-treated epileptic patients.
    Bar S, Feller N, Savir H.
    Arch Ophthalmol; 1983 Mar 12; 101(3):422-5. PubMed ID: 6830496
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.